BioScale Receives $25,000,000 New Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    75 Sidney Street 3rd Floor Cambridge, MA 02139-4134
  • Company Description
    The company develops nanotechnology-focused biological technologies.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    The financing willprovide the resources to bring BioScale’s ViBE product line into the market and establishBioScale as a leader in protein analytics technology.
  • M&A Terms
  • Venture Investor
    Morningside Group
  • Venture Investor
    F-2 Ventures
  • Venture Investor
    New Science Ventures
  • Venture Investor
    WFD Ventures
  • Venture Investor

Trending on Xconomy